Skip to main content

Table 1 General characteristics of experimental group

From: N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats

  C D D + NAC
Plasma glucose (mM) 6.41 ± 0.61 29.12 ± 5.13** 25.86 ± 2.76**
Heart weight (g) 1.62 ± 0.23 1.21 ± 0.17* 1.38 ± 0.20*
Body weight (g) 450.5 ± 20.3 263.7 ± 17.6* 362.5 ± 24.2*#
Heart weight/bodyweight (mg/g) 3.59 ± 0.09 4.58 ± 0.12* 3.81 ± 0.11#
  1. Control (C) or STZ-induced diabetic (D) rats were either untreated or treated with N-acetylcysteine (1.5 g/kg/day, D + NAC) by oral gavage for 4 weeks. All the results are expressed as mean ± SD, n = 8. Differences in general characteristics among the three groups were determined by using one-way ANOVA followed by Tukey’s test
  2. * P < 0.05
  3. ** P < 0.01 vs. C group
  4. # P < 0.05 vs. D group